Skip to main content
Top
Published in: Cancer Cell International 1/2017

Open Access 01-12-2017 | Primary Research

Secretory phospholipase-A2 and fatty acid composition in oral reactive lesions: a cross-sectional study

Authors: Ali Hossein Mesgarzadeh, Abolfazl Akbarzadeh, Ali Rasipour, Tannaz Rasipour, Amir Mehdizadeh, Maghsod Shaaker

Published in: Cancer Cell International | Issue 1/2017

Login to get access

Abstract

Background

Oral reactive lesions are the most common lesions of oral cavity. Phospholipases and fatty acids play key roles in the creation of inflammation by change in metabolic activities and production of lipid mediators. The aim of this study was to investigate the amount of secretory phospholipase-A2 (sPLA2) and difference of fatty acid pattern in oral reactive hyperplasia and adjacent normal appearing tissues in patients with oral reactive lesions.

Methods

Paired samples of oral hyperplastic (OH) and adjacent normal-appearing tissue of 45 patients were investigated in this study. The collected samples were analyzed with enzymatic spectrophotometric method in terms of the amount of sPLA2 and composition of fatty acids by gas–liquid chromatography method.

Results

The amount of sPLA2 (1.8-fold, p < 0.001), stearic acid (1.2-fold, p < 0.001), oleic acid (1.1-fold, p = 0.01), arachidonic acid (1.5-fold, p < 0.001) and docosahexaenoic acid (1.3-fold, p = 0.02) were increased, while the amount of palmitoleic acid (−45%, p < 0.001) and linoleic acid (−19%, p < 0.001) were reduced in the OH tissue samples. Furthermore, the results demonstrated significant associations between the type and location of tissue samples with monounsaturated fatty acids (MUFAs) and n−3 polyunsaturated fatty acids. Tissue samples from patients with inflammatory fibroepithelial hyperplasia showed relatively higher MUFAs and lower n−3 polyunsaturated fatty acids than other type of lesions.

Conclusions

Localized changes in the sPLA2 activity and composition of fatty acid are associated with oral reactive hyperplasia and the type of pathological response. We suggest that sPLA2 activity and multiple type of fatty acids might be used as potential therapeutic target for oral reactive hyperplasia.
Literature
1.
go back to reference Effiom OA, Adeyemo WL, Soyele OO. Focal Reactive lesions of the Gingiva: an Analysis of 314 cases at a tertiary Health Institution in Nigeria. Niger Med J. 2011;52:35–40.PubMedPubMedCentral Effiom OA, Adeyemo WL, Soyele OO. Focal Reactive lesions of the Gingiva: an Analysis of 314 cases at a tertiary Health Institution in Nigeria. Niger Med J. 2011;52:35–40.PubMedPubMedCentral
3.
go back to reference Taketomi Y, Ueno N, Kojima T, Sato H, Murase R, Yamamoto K, et al. Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. Nat Immunol. 2013;14:554–63.CrossRefPubMedPubMedCentral Taketomi Y, Ueno N, Kojima T, Sato H, Murase R, Yamamoto K, et al. Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis. Nat Immunol. 2013;14:554–63.CrossRefPubMedPubMedCentral
4.
go back to reference Askari M, Darabi M, Zare Mahmudabadi R, Oboodiat M, Fayezi S, Mostakhdemin Hosseini Z, et al. Tissue fatty acid composition and secretory phospholipase-A2 activity in oral squamous cell carcinoma. Oncol: Clin Transl; 2014. Askari M, Darabi M, Zare Mahmudabadi R, Oboodiat M, Fayezi S, Mostakhdemin Hosseini Z, et al. Tissue fatty acid composition and secretory phospholipase-A2 activity in oral squamous cell carcinoma. Oncol: Clin Transl; 2014.
5.
go back to reference Dong Q, Patel M, Scott KF, Graham GG, Russell PJ, Sved P. Oncogenic action of phospholipase A2 in prostate cancer. Cancer Lett. 2006;240:9–16.CrossRefPubMed Dong Q, Patel M, Scott KF, Graham GG, Russell PJ, Sved P. Oncogenic action of phospholipase A2 in prostate cancer. Cancer Lett. 2006;240:9–16.CrossRefPubMed
6.
go back to reference Yamashita S, Ogawa M, Sakamoto K, Abe T, Arakawa H, Yamashita J. Elevation of serum group II phospholipase A2 levels in patients with advanced cancer. Clin Chim Acta. 1994;228:91–9.CrossRefPubMed Yamashita S, Ogawa M, Sakamoto K, Abe T, Arakawa H, Yamashita J. Elevation of serum group II phospholipase A2 levels in patients with advanced cancer. Clin Chim Acta. 1994;228:91–9.CrossRefPubMed
7.
go back to reference Ezzeddini R, Darabi M, Ghasemi B, Jabbari Y, Abdollahi S, Rashtchizadeh N, et al. Circulating phospholipase-A2 activity in obstructive sleep apnea and recurrent tonsillitis. Int J Pediatr Otorhinolaryngol. 2012;76:471–4.CrossRefPubMed Ezzeddini R, Darabi M, Ghasemi B, Jabbari Y, Abdollahi S, Rashtchizadeh N, et al. Circulating phospholipase-A2 activity in obstructive sleep apnea and recurrent tonsillitis. Int J Pediatr Otorhinolaryngol. 2012;76:471–4.CrossRefPubMed
8.
go back to reference Ezzedini R, Darabi M, Ghasemi B, Darabi M, Fayezi S, Moghaddam YJ, et al. Tissue fatty acid composition in obstructive sleep apnea and recurrent tonsillitis. Int J Pediatr Otorhinolaryngol. 2013;77:1008–12.CrossRefPubMed Ezzedini R, Darabi M, Ghasemi B, Darabi M, Fayezi S, Moghaddam YJ, et al. Tissue fatty acid composition in obstructive sleep apnea and recurrent tonsillitis. Int J Pediatr Otorhinolaryngol. 2013;77:1008–12.CrossRefPubMed
11.
go back to reference Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27:114–20.PubMed Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res. 1986;27:114–20.PubMed
12.
go back to reference Forlenza OV, Schaeffer EL, Gattaz WF. The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer’s disease. J Neural Transm. 2007;114:231–8.CrossRefPubMed Forlenza OV, Schaeffer EL, Gattaz WF. The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer’s disease. J Neural Transm. 2007;114:231–8.CrossRefPubMed
13.
go back to reference Tong LJ, Dong LW, Liu MS. GTP-binding protein mediated phospholipase A2 activation in rat liver during the progression of sepsis. Mol Cell Biochem. 1998;189:55–61.CrossRefPubMed Tong LJ, Dong LW, Liu MS. GTP-binding protein mediated phospholipase A2 activation in rat liver during the progression of sepsis. Mol Cell Biochem. 1998;189:55–61.CrossRefPubMed
14.
go back to reference Rosenson RS, Hurt-Camejo E. Phospholipase A2 enzymes and the risk of atherosclerosis. Eur Heart J. 2012;33:2899–909.CrossRefPubMed Rosenson RS, Hurt-Camejo E. Phospholipase A2 enzymes and the risk of atherosclerosis. Eur Heart J. 2012;33:2899–909.CrossRefPubMed
15.
go back to reference Murakami M, Masuda S, Shimbara S, Ishikawa Y, Ishii T, Kudo I. Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A2. J Biol Chem. 2005;280:24987–98.CrossRefPubMed Murakami M, Masuda S, Shimbara S, Ishikawa Y, Ishii T, Kudo I. Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A2. J Biol Chem. 2005;280:24987–98.CrossRefPubMed
16.
go back to reference Jiang J, Neubauer BL, Graff JR, Chedid M, Thomas JE, Roehm NW, et al. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Pathol. 2002;160:667–71.CrossRefPubMedPubMedCentral Jiang J, Neubauer BL, Graff JR, Chedid M, Thomas JE, Roehm NW, et al. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Pathol. 2002;160:667–71.CrossRefPubMedPubMedCentral
17.
go back to reference Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461–6.CrossRefPubMed Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 2004;431:461–6.CrossRefPubMed
18.
go back to reference Celenk F, Bayramoglu I, Yilmaz A, Menevse A, Bayazit Y. Expression of cyclooxygenase-2, 12-lipoxygenase, and inducible nitric oxide synthase in head and neck squamous cell carcinoma. J Craniofac Surg. 2013;24:1114–7.CrossRefPubMed Celenk F, Bayramoglu I, Yilmaz A, Menevse A, Bayazit Y. Expression of cyclooxygenase-2, 12-lipoxygenase, and inducible nitric oxide synthase in head and neck squamous cell carcinoma. J Craniofac Surg. 2013;24:1114–7.CrossRefPubMed
19.
go back to reference Cummings BS. Phospholipase A2 as targets for anti-cancer drugs. Biochem Pharmacol. 2007;74:949–59.CrossRefPubMed Cummings BS. Phospholipase A2 as targets for anti-cancer drugs. Biochem Pharmacol. 2007;74:949–59.CrossRefPubMed
21.
go back to reference Ciçek Y, Ozmen I, Canakçi V, Dilsiz A, Sahin F. Content and composition of fatty acids in normal and inflamed gingival tissues. Prostaglandins Leukot Essent Fatty Acids. 2005;72:147–51.CrossRefPubMed Ciçek Y, Ozmen I, Canakçi V, Dilsiz A, Sahin F. Content and composition of fatty acids in normal and inflamed gingival tissues. Prostaglandins Leukot Essent Fatty Acids. 2005;72:147–51.CrossRefPubMed
22.
go back to reference Ghosh M, Tucker DE, Burchett SA, Leslie CC. Properties of the Group IV phospholipase A2 family. Prog Lipid Res. 2006;45:487–510.CrossRefPubMed Ghosh M, Tucker DE, Burchett SA, Leslie CC. Properties of the Group IV phospholipase A2 family. Prog Lipid Res. 2006;45:487–510.CrossRefPubMed
24.
go back to reference Thommesen L, Sjursen W, Gåsvik K, Hanssen W, Brekke OL, Skattebøl L, et al. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. J Immunol. 1998;161:3421–30.PubMed Thommesen L, Sjursen W, Gåsvik K, Hanssen W, Brekke OL, Skattebøl L, et al. Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappa B and expression of ICAM-1. J Immunol. 1998;161:3421–30.PubMed
25.
go back to reference Tanaka T, Ogura R, Hidaka T, Sugiyama M. Changes of electron spin resonance membrane fluidity in hexadecane-induced hyperproliferative epidermis. J Invest Dermatol. 1989;93:682–6.CrossRefPubMed Tanaka T, Ogura R, Hidaka T, Sugiyama M. Changes of electron spin resonance membrane fluidity in hexadecane-induced hyperproliferative epidermis. J Invest Dermatol. 1989;93:682–6.CrossRefPubMed
27.
go back to reference Laviano A, Rianda S, Molfino A, Rossi Fanelli F. Omega-3 fatty acids in cancer. Curr Opin Clin Nutr Metab Care. 2013;16:156–61.CrossRefPubMed Laviano A, Rianda S, Molfino A, Rossi Fanelli F. Omega-3 fatty acids in cancer. Curr Opin Clin Nutr Metab Care. 2013;16:156–61.CrossRefPubMed
28.
go back to reference Bazan NG, Molina MF, Gordon WC. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative diseases. Annu Rev Nutr. 2011;31:321–51.CrossRefPubMedPubMedCentral Bazan NG, Molina MF, Gordon WC. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer’s, and other neurodegenerative diseases. Annu Rev Nutr. 2011;31:321–51.CrossRefPubMedPubMedCentral
29.
go back to reference Wang S-H, Hung H-C, Tsai C-C, Huang M-C, Ho K-Y, Wu Y-M, et al. Plasma polyunsaturated fatty acids and periodontal recovery in Taiwanese with periodontitis: a significant relationship. Arch Oral Biol. 2014;59:800–7.CrossRefPubMed Wang S-H, Hung H-C, Tsai C-C, Huang M-C, Ho K-Y, Wu Y-M, et al. Plasma polyunsaturated fatty acids and periodontal recovery in Taiwanese with periodontitis: a significant relationship. Arch Oral Biol. 2014;59:800–7.CrossRefPubMed
30.
go back to reference Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365–79.CrossRefPubMed Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002;56:365–79.CrossRefPubMed
31.
go back to reference Iwasaki M, Manz MC, Moynihan P, Yoshihara A, Muramatsu K, Watanabe R, et al. Relationship between saturated fatty acids and periodontal disease. J Dent Res. 2011;90:861–7.CrossRefPubMed Iwasaki M, Manz MC, Moynihan P, Yoshihara A, Muramatsu K, Watanabe R, et al. Relationship between saturated fatty acids and periodontal disease. J Dent Res. 2011;90:861–7.CrossRefPubMed
32.
go back to reference Bunn RC, Cockrell GE, Ou Y, Thrailkill KM, Lumpkin CK Jr, Fowlkes JL. Palmitate and insulin synergistically induce IL-6 expression in human monocytes. Cardiovasc Diabetol. 2010;9:73.CrossRefPubMedPubMedCentral Bunn RC, Cockrell GE, Ou Y, Thrailkill KM, Lumpkin CK Jr, Fowlkes JL. Palmitate and insulin synergistically induce IL-6 expression in human monocytes. Cardiovasc Diabetol. 2010;9:73.CrossRefPubMedPubMedCentral
33.
go back to reference Hu W, Ross J, Geng T, Brice SE, Cowart LA. Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance. J Biol Chem. 2011;286:16596–605.CrossRefPubMedPubMedCentral Hu W, Ross J, Geng T, Brice SE, Cowart LA. Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance. J Biol Chem. 2011;286:16596–605.CrossRefPubMedPubMedCentral
35.
go back to reference Naughton SS, Mathai ML, Hryciw DH, McAinch AJ. Linoleic acid and the pathogenesis of obesity. Prostaglandins Other Lipid Mediat. 2016;125:90–9.CrossRefPubMed Naughton SS, Mathai ML, Hryciw DH, McAinch AJ. Linoleic acid and the pathogenesis of obesity. Prostaglandins Other Lipid Mediat. 2016;125:90–9.CrossRefPubMed
Metadata
Title
Secretory phospholipase-A2 and fatty acid composition in oral reactive lesions: a cross-sectional study
Authors
Ali Hossein Mesgarzadeh
Abolfazl Akbarzadeh
Ali Rasipour
Tannaz Rasipour
Amir Mehdizadeh
Maghsod Shaaker
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2017
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-017-0414-x

Other articles of this Issue 1/2017

Cancer Cell International 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine